Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Savings, Specialty Drugs
The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...
Jun 1, 2021 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings, Transparency
MedBen Rx clients save 21.6% when switching from traditional PBMs. What accounts for such a substantial difference? With MedBen Rx you pay what the pharmacy pays – we use the drug’s acquisition cost as a baseline to reduce your costs. MedBen Rx offers total...
May 17, 2021 | Comparative Effectiveness, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings
MedBen Rx clients can save between 10-30% by using comparative effectiveness focusing on the best drug outcomes. One way it does this is by dispelling the costly misperception that “new is better.” “A new FDA approved drug doesn’t mean it’s better than existing...
Nov 23, 2020 | Brand Name Drugs, Generic Drugs, MedBen Access, MedBen Rx, Online Services, Prescription drugs, Rx Costs, Rx Facts, Savings
On December 1, MedBen Rx will roll out the new Member Prescription Portal. This easy-to-navigate site, available online through MedBen Access or via our mobile app, is designed to help members better manage their pharmacy plan and make cost-effective prescription drug...
Oct 16, 2020 | MedBen Rx, Prescription drugs, Rx Spending, Savings, Transparency
A National Alliance of Healthcare Purchaser Coalitions survey asked employers what they thought were the greatest threats to coverage affordability. Their responses… and how MedBen counters these concerns with proven saving solutions: Drug prices are a threat to...
Sep 5, 2020 | Prescription drugs, Specialty Drugs
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
